Monkeys sickened by Marburg virus, an Ebola relative that kills in the same way and is equally as fatal, survived the disease after being treated with an experimental drug developed by Tekmira Pharmaceuticals Corp. (TKMR)
The results, published today in the journal Science Translational Medicine, are the first to show the drug can be successful even with delayed treatment, suggesting a potential use in outbreaks. Emerging infectious diseases, from AIDS to Ebola, Marburg, Chikungunya and hantavirus have thrown a scare into the world over the past decade as the number of outbreaks and their geographic range has increased.
Tekmira is one of several companies working to find a way to slow their march, even as an Ebola outbreak in West Africa has killed at least 1,350 people. Marburg, like Ebola, causes bleeding that can lead to organ shutdown. The Tekmira drug is based on the same gene-silencing technology as a treatment the Vancouver-based company is testing for Ebola.

http://mobile.bloomberg.com/news/2014-08-20/ebola-like-virus-beaten-by-tekmira-treatment-in-study.html